Niagen Bioscience, Inc. Annual Operating Lease, Payments in USD from 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Niagen Bioscience, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2021 to 2024.
  • Niagen Bioscience, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $91K, a 49.4% decline year-over-year.
  • Niagen Bioscience, Inc. annual Operating Lease, Payments for 2024 was $600K, a 1.64% decline from 2023.
  • Niagen Bioscience, Inc. annual Operating Lease, Payments for 2023 was $610K, a 20.3% increase from 2022.
  • Niagen Bioscience, Inc. annual Operating Lease, Payments for 2022 was $507K, a 6.29% decline from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $600K -$10K -1.64% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-04
2023 $610K +$103K +20.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-04
2022 $507K -$34K -6.29% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $541K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.